Cambridge Investment Research Advisors’s Lydall, Inc. LDL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio LDL Stock Details LDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,200	Closed	-$261K	–	3339
2021 Q3	$261K	Sell	4,200 -2,760	-40%	-$170K	﹤0.01%	2578
2021 Q2	$421K	Sell	6,960 -32,575	-82%	-$1.25M	﹤0.01%	2198
2021 Q1	$1.33M	Sell	39,535 -8,260	-17%	-$283K	0.01%	1242
2020 Q4	$1.44M	Buy	47,795 +7,075	+17%	+$170K	0.01%	1102
2020 Q3	$674K	Buy	40,720 +7,570	+23%	+$132K	﹤0.01%	1416
2020 Q2	$450K	Buy	+33,150	New	+$367K	﹤0.01%	1622

Cambridge Investment Research Advisors's LDL Position: Q4 2021 in Review

Cambridge Investment Research Advisors sold out of Lydall, Inc. (LDL) in Q4 2021, closing a stake of 4,200 shares — an estimated $261K sold.

Cambridge Investment Research Advisors first reported a position in LDL in Q2 2020 and held it in 6 quarters. The position peaked at $1.44M in Q4 2020. 1 fund tracked by Wall St. Rank holds LDL as of Q4 2021.

Cambridge Investment Research Advisors reported no remaining Lydall, Inc. position as of Q4 2021 after selling out during the quarter.
Cambridge Investment Research Advisors sold 4,200 Lydall, Inc. shares in Q4 2021, an estimated $261K.
Cambridge Investment Research Advisors first reported a position in Lydall, Inc. in Q2 2020 and held it in 6 quarters.
Cambridge Investment Research Advisors's Lydall, Inc. position peaked at $1.44M in Q4 2020.
1 fund tracked by Wall St. Rank held Lydall, Inc. as of Q4 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.